Chemoimmunotherapy May Not Be Dead Yet in Chronic Lymphocytic Leukemia, But Fludarabine Plus Cyclophosphamide Plus Rituximab Is Potentially Facing Life Support.

Opat, Stephen; Hawkes, Eliza A

doi:10.1200/JCO.2017.75.4721

Austin Health

Title

Chemoimmunotherapy May Not Be Dead Yet in Chronic Lymphocytic Leukemia, But Fludarabine Plus Cyclophosphamide Plus Rituximab Is Potentially Facing Life Support.

Publication Date

2017-12-20

Author(s)

Opat, Stephen

Hawkes, Eliza A

Type of document

Journal Article

DOI

10.1200/JCO.2017.75.4721

Link

link

Citation

Journal of Clinical Oncology 2017; 35(36): 4093-4094

Jornal Title

Journal of Clinical Oncology

Files:

Name	Size	format	Description	Link